Diagnostic performance of serum steatosis biomarkers in Prediction of Non Alcoholic Fatty Liver Disease in Adult Asymptomatic Egyptians - Egyptian Knowledge Bank - troweb

222747

Diagnostic performance of serum steatosis biomarkers in Prediction of Non Alcoholic Fatty Liver Disease in Adult Asymptomatic Egyptians

Article

Last updated: 04 Jan 2025

Overview Similar Items

Article

Correlation between Liver function tests, lipid profile and fibroscan in non-alcoholic fatty liver disease

Article

Anthropometric Measures as Predictors of Non-Alcoholic Fatty Liver Disease in Adult Asymptomatic Egyptians

Article

Frequency of Metabolic Associated Fatty Liver Disease among Chronic Kidney Disease Patients in Upper Egypt

Article

Evaluation of Triglyceride-Glucose Index as a Marker of Hepatic Steatosis and Fibrosis in Egyptian Patients with NAFLD

Article

Non-Alcoholic Fatty Liver Disease in Cardiovascular Patients, Frequency, Risk Factors and Clinical Patterns in Qena Governorate

Article

Relationship between Elevated Liver enzymes and Metabolic syndrome among Egyptian adults

Article

STUDY OF PENTRAXIN-3 LEVELS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AMONG EGYPTIAN PATIENTS

Article

Study of prevelance of Metabolic associated Fatty Liver Disease (MAFLD) in Fayoum Governorate

Article

Clinical Patterns and Risk Factors for Non-Alcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease in Upper Egypt

Article

Diagnostic and Prognostic Validity of Serum Golgi Protein 73 in Egyptian Patients with Hepatocelluar Carcinoma